- Home
- ZNTL vs XCBE Comparison
ZNTL vs XCBE Comparison
Compare ZNTL & XCBE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$4.49
Company Overview
Basic Information| Metric | ZNTL | XCBE |
|---|---|---|
| Founded | 2014 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 289.0M | 279.3M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ZNTL | XCBE |
|---|---|---|
| Price | $4.49 | $9.99 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $6.60 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 117.2K |
| Earning Date | 05-07-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.03 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.15 | $9.75 |
| 52 Week High | $6.95 | $9.99 |
Technical Indicators
Market Signals| Indicator | ZNTL | XCBE |
|---|---|---|
| Relative Strength Index (RSI) | 59.31 | 76.16 |
| Support Level | $3.53 | $9.88 |
| Resistance Level | $6.95 | N/A |
| Average True Range (ATR) | 0.38 | 0.01 |
| MACD | 0.10 | 0.01 |
| Stochastic Oscillator | 60.37 | 100.00 |
Price Performance
Historical Comparison ZNTL
XCBE
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About XCBE X3 Acquisition Corp. Ltd. Class A Ordinary Shares
X3 Acquisition Corp Ltd is a blank check company.